Literature DB >> 28384925

SLE and Tuberculosis: A Case Series and Review of Literature.

Prasanta Kumar Bhattacharya1, Md Jamil2, Aakash Roy3, Kishore Kumar Talukdar3.   

Abstract

Systemic Lupus Erythematosus (SLE) and Tuberculosis (TB) are intricately related with an increase in the risk of TB in SLE. Primary mechanisms pertaining to the increased susceptibility for TB are the inherent immunodeficient state of SLE and use of immunosuppressant agents in the treatment of SLE. We report a case series of five female patients of SLE with TB who presented between January 2015 and December 2015 in a tertiary care teaching hospital in North Eastern India. All the patients were young to middle aged females having SLE with or without lupus nephritis who were on immunosuppressive therapy with corticosteroids, mycophenolate mofetil or cyclophosphamide. Two of the cases had sputum positive pulmonary tuberculosis while rest had Extra-Pulmonary TB (EPTB). The response to anti-tubercular therapy led to clinical improvement in all the cases except one who had an adverse outcome. Our series further substantiates the increased risk of TB in SLE thus, prompting further research towards better management of these two disease entities in conjunction.

Entities:  

Keywords:  Auto-immunity; Immunosuppression; Lupus; Tubercular infection

Year:  2017        PMID: 28384925      PMCID: PMC5376776          DOI: 10.7860/JCDR/2017/22749.9398

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

Review 2.  Infections in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  E Bouza; J G Moya; P Muñoz
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

Review 3.  Diagnosis and classification of drug-induced autoimmunity (DIA).

Authors:  Xiao Xiao; Christopher Chang
Journal:  J Autoimmun       Date:  2014-01-21       Impact factor: 7.094

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  High risk of tuberculosis in systemic lupus erythematosus?

Authors:  J G Erdozain; G Ruiz-Irastorza; M V Egurbide; A Martinez-Berriotxoa; C Aguirre
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 6.  Systemic lupus erythematosus and tuberculosis: a review of complex interactions of complicated diseases.

Authors:  Vnn Prabu; S Agrawal
Journal:  J Postgrad Med       Date:  2010 Jul-Sep       Impact factor: 1.476

7.  Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.

Authors:  Mo Yin Mok; Yi Lo; Tak Mao Chan; Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

8.  Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.

Authors:  Lai-Shan Tam; Edmund K Li; Shiu-Man Wong; Cheuk-Chun Szeto
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

9.  Active and latent tuberculosis in patients with systemic lupus erythematosus living in the United States.

Authors:  Alvina D Chu; Andrea H Polesky; Gulshan Bhatia; Thomas M Bush
Journal:  J Clin Rheumatol       Date:  2009-08       Impact factor: 3.517

10.  Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared.

Authors:  Chih-Lung Hou; Yi-Chan Tsai; Li-Chen Chen; Jing-Long Huang
Journal:  Clin Rheumatol       Date:  2007-10-17       Impact factor: 2.980

View more
  6 in total

1.  Tuberculous fasciitis in a patient with systemic lupus erythematosus.

Authors:  Takahiko Akagi; Hiroyasu Hirano; Shunichi Fujita; Yoshitaka Morita
Journal:  BMJ Case Rep       Date:  2019-07-22

2.  Disseminated tuberculosis with macrophage activation syndrome in a child with lupus nephritis.

Authors:  Mahesh Janarthanan; Tessa Antony; Ram Mohan; Sarala Premkumar; Umapathy Pasupathy
Journal:  Sudan J Paediatr       Date:  2021

3.  High Prevalence of Active Tuberculosis in Adults and Children with Idiopathic Inflammatory Myositis as Compared with Systemic Lupus Erythematosus in a Tuberculosis Endemic Country: Retrospective Data Review from a Tertiary Care Centre in India.

Authors:  Latika Gupta; Rohit Aggarwal; R Naveen; Able Lawrence; Abhishek Zanwar; Durga Prasanna Misra; Vikas Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  Mediterr J Rheumatol       Date:  2021-06-30

4.  Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results.

Authors:  Winni Maharani; Dwi Febni Ratnaningsih; Fitria Utami; Fajar Awalia Yulianto; Anneke Dewina; Laniyati Hamijoyo; Nur Atik
Journal:  J Inflamm Res       Date:  2020-08-14

5.  Miliary Tuberculosis Presenting With Meningitis in a Patient Treated With Mycophenolate for Lupus Nephritis: Challenges in Diagnosis and Review of the Literature.

Authors:  Precious Macauley; Mark Rapp; Sarah Park; Olaoluwatomi Lamikanra; Pratibha Sharma; Michael Marcelin; Kavita Sharma
Journal:  J Investig Med High Impact Case Rep       Date:  2018-04-18

Review 6.  An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.

Authors:  Milla R McLean; Lenette L Lu; Stephen J Kent; Amy W Chung
Journal:  Front Immunol       Date:  2019-12-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.